{"id":14196,"date":"2026-01-12T12:05:31","date_gmt":"2026-01-12T12:05:31","guid":{"rendered":"https:\/\/readtrends.com\/en\/exercise-equal-medication-depression\/"},"modified":"2026-01-12T12:05:31","modified_gmt":"2026-01-12T12:05:31","slug":"exercise-equal-medication-depression","status":"publish","type":"post","link":"https:\/\/readtrends.com\/en\/exercise-equal-medication-depression\/","title":{"rendered":"Exercise is as effective as medication in treating depression, study finds"},"content":{"rendered":"<article>\n<p><strong>Lead:<\/strong> A new Cochrane review published on Jan. 12, 2026, finds that structured physical activity can relieve depressive symptoms as effectively as pharmacological or psychological treatments in many cases. Researchers analyzed 73 randomized controlled trials involving roughly 5,000 people with depression, including participants who were also taking antidepressants. The evidence shows that even light-to-moderate activity \u2014 and combinations of aerobic and resistance training \u2014 produced measurable symptom relief within a few weeks of regular sessions.<\/p>\n<h2>Key Takeaways<\/h2>\n<ul>\n<li>The review pooled 73 randomized controlled trials with about 5,000 participants and concluded exercise produced improvements comparable to medication or therapy in many studies.<\/li>\n<li>Benefits were seen with light-to-moderate activity; people who became slightly breathless during exercise saw gains early on.<\/li>\n<li>Combinations of aerobic and resistance training outperformed aerobic-only programs in the trials that compared modalities.<\/li>\n<li>The meta-analysis reported clinical improvement after roughly 13 to 36 exercise sessions, though long-term follow-up data were limited.<\/li>\n<li>Proposed mechanisms include increased neurotransmitter functioning (serotonin, dopamine, endorphins) and higher brain-derived neurotrophic factor (BDNF).<\/li>\n<li>Global clinical guidelines increasingly list exercise as a front-line or adjunctive treatment, but real-world implementation and adherence remain challenges.<\/li>\n<li>Exercise is low-cost with minimal side effects and can deliver mental, social and physical benefits when tailored to the individual.<\/li>\n<\/ul>\n<h2>Background<\/h2>\n<p>The Cochrane Collaboration, an independent international network that synthesizes randomized trial evidence, systematically reviewed trials testing exercise as a treatment for clinical depression. Trials spanned community and clinical settings and included participants who were treatment-na\u00efve as well as those concurrently using antidepressants. Prior research has suggested mood benefits from physical activity, but this review aimed to compare exercise\u2019s effect size directly with pharmacological and psychological interventions.<\/p>\n<p>Depression is a leading cause of disability worldwide and a common reason patients seek primary care. Standard treatments include antidepressants and psychotherapies, but access, side effects and variable response rates leave many patients seeking alternatives or complements. Exercise has long been proposed as a scalable option, but clinicians have faced uncertainty about optimal dose, modality and how exercise compares with established treatments in randomized trials.<\/p>\n<h2>Main Event<\/h2>\n<p>Investigators pooled 73 randomized controlled trials involving roughly 5,000 adults diagnosed with depression. Across the analyzed studies, structured exercise programs\u2014ranging from walking and jogging to mixed aerobic-and-resistance routines\u2014were randomized against usual care, psychological therapy, pharmacotherapy or attention controls. The review found that, on average, exercise reduced depressive symptoms to a degree similar to medication or therapy in many trials included in the synthesis.<\/p>\n<p>Authors and commentators emphasized the practical implications. Andrew Clegg, a professor at the University of Lancashire who contributed to the review, noted the similarity in effectiveness between exercise and other established treatments. Clinicians quoted in reporting highlighted that even modest increases in activity can produce clinically meaningful changes, particularly early in treatment when even low-dose activity may boost engagement and mood.<\/p>\n<p>Mechanistic explanations reported alongside the review point to both neurochemical and neurotrophic effects. Clinicians described overlapping biochemical pathways with antidepressants\u2014exercise can raise levels of serotonin, dopamine and endorphins\u2014while also increasing neuroplasticity via factors such as BDNF. Trials that combined aerobic and strength training tended to show larger symptom reductions than aerobic-only programs in those head-to-head comparisons.<\/p>\n<p>Despite favorable short-term outcomes, the reviewers and external experts flagged gaps: many trials were brief, and sustained long-term benefits, relapse prevention and adherence over months or years remain less well documented. Researchers also warned that quality and reporting of some trials varied, affecting certainty about subgroup effects and optimal prescriptions for different patient populations.<\/p>\n<h2>Analysis &#038; Implications<\/h2>\n<p>The review\u2019s conclusion that exercise can rival medication or therapy in symptom reduction reshapes how clinicians might present treatment options. For patients hesitant about medication or seeking complementary strategies, clinicians can now reliably discuss exercise as an evidence-based choice, not merely lifestyle advice. That said, equivalence in average effect size does not mean identical benefit for every individual; personalized care remains essential.<\/p>\n<p>From a public-health perspective, exercise as a treatment offers advantages: low cost, broad accessibility and collateral benefits for physical health. Scaling exercise interventions\u2014group programs, community prescriptions, structured clinician referrals\u2014could reduce treatment gaps, but implementation requires resources for coaching, supervision and behavioral support to sustain adherence, especially for people with severe motivational deficits caused by depression.<\/p>\n<p>Economically, increased use of exercise interventions could lower some medication- and therapy-related expenditures, but it also demands investment in delivery systems (trained facilitators, safe spaces, monitoring). Insurers and health systems that reimburse structured exercise programs or community-based initiatives may accelerate adoption and provide comparative data on long-term cost-effectiveness.<\/p>\n<h2>Comparison &#038; Data<\/h2>\n<figure>\n<table>\n<thead>\n<tr>\n<th>Measure<\/th>\n<th>Value (from review)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Randomized trials analyzed<\/td>\n<td>73<\/td>\n<\/tr>\n<tr>\n<td>Participants (approx.)<\/td>\n<td>5,000<\/td>\n<\/tr>\n<tr>\n<td>Sessions linked to improvement<\/td>\n<td>13\u201336 workouts<\/td>\n<\/tr>\n<tr>\n<td>Effective intensities<\/td>\n<td>Light to moderate (with gradual progression)<\/td>\n<\/tr>\n<tr>\n<td>Modality with greater benefit<\/td>\n<td>Aerobic + resistance training<\/td>\n<\/tr>\n<\/tbody>\n<\/table><figcaption>Summary metrics from the Cochrane review synthesized across trials.<\/figcaption><\/figure>\n<p>The table summarizes the core quantitative findings reported in the review. While short-term symptom reductions were consistently observed across studies, heterogeneity in trial designs\u2014differences in diagnostic criteria, supervision levels, and comparator arms\u2014limits precision about the single optimal \u201cdose.\u201d The reviewers note a need for larger, longer trials with standardized outcome measures to clarify durability and subgroup effects.<\/p>\n<h2>Reactions &#038; Quotes<\/h2>\n<p>The review drew responses from clinicians who see exercise as a practical treatment option but emphasize implementation barriers. Below are representative statements with context.<\/p>\n<blockquote>\n<p>&#8220;We found that exercise was as effective as pharmacological treatments or psychological therapies as well.&#8221;<\/p>\n<p>  <cite>Andrew Clegg, University of Lancashire<\/cite>\n<\/p><\/blockquote>\n<p>Clegg\u2019s summary reflects the pooled comparisons in the review; he and coauthors caution that trial quality and follow-up length affect confidence in exact equivalence but say the overall signal supports exercise as a credible treatment pathway.<\/p>\n<blockquote>\n<p>&#8220;This review reinforces the evidence that exercise is one of the most evidence-based tools for improving mood.&#8221;<\/p>\n<p>  <cite>Dr. Stephen Mateka, Medical Director of Psychiatry, Inspira Health<\/cite>\n<\/p><\/blockquote>\n<p>Mateka highlighted clinical utility: exercise can be an accessible option with minimal adverse effects. He and other clinicians note, however, that prescribing exercise requires time, behavioral support and systems-level changes for broad uptake.<\/p>\n<blockquote>\n<p>&#8220;The brain in depression is thought to be less plastic&#8230;we know that exercise can also boost [BDNF].&#8221;<\/p>\n<p>  <cite>Dr. Nicholas Fabiano, University of Ottawa<\/cite>\n<\/p><\/blockquote>\n<p>Fabiano emphasized biological plausibility\u2014exercise counters neuroplasticity deficits by increasing neurotrophic factors\u2014supporting why activity can produce measurable clinical effects beyond mood alone.<\/p>\n<aside>\n<details>\n<summary>Explainer: How exercise may improve depression<\/summary>\n<p>Exercise influences mood through several biological and psychosocial pathways. Biologically, physical activity elevates monoamine neurotransmitters (serotonin, dopamine) and endorphins, which can improve mood and reduce pain perception. It also increases brain-derived neurotrophic factor (BDNF), supporting synaptic plasticity and learning, which may help the brain recover from depressive states. Psychosocially, exercise can enhance self-efficacy, social connection (especially in group formats), and sleep quality\u2014all factors that stabilize mood. Clinically, gradual, achievable activity targets and combining aerobic with resistance work tend to improve adherence and outcomes. Implementation benefits from behavior-change support such as brief counseling, goal-setting and follow-up.<\/p>\n<\/details>\n<\/aside>\n<h2>Unconfirmed<\/h2>\n<ul>\n<li>Whether exercise prevents new onset of major depressive episodes over the long term remains inadequately tested in large trials.<\/li>\n<li>Precise equivalence of exercise to medication for people with severe, recurrent, or treatment-resistant depression is not fully established.<\/li>\n<li>Optimal long-term dose, frequency and supervision level needed to sustain benefits across diverse populations require further confirmation.<\/li>\n<\/ul>\n<h2>Bottom Line<\/h2>\n<p>The Cochrane review strengthens the evidence that structured exercise is a legitimate, evidence-based treatment option for depression that often produces symptom improvements comparable to medication or psychotherapy in randomized trials. Even modest, light-to-moderate activity\u2014especially when combining aerobic and resistance work\u2014can yield meaningful reductions in depressive symptoms within several weeks.<\/p>\n<p>For clinicians and policymakers, the priority now is translating these findings into practice: provide individualized exercise prescriptions, behavioral support to improve uptake and retention, and funding for programs that make activity safe and accessible. For patients, the findings mean that, alongside medication or therapy when appropriate, adopting regular movement\u2014starting low and building up\u2014can be a powerful component of recovery.<\/p>\n<h2>Sources<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.npr.org\/2026\/01\/12\/nx-s1-5667599\/exercise-is-as-effective-as-medication-in-treating-depression-study-finds\" target=\"_blank\" rel=\"noopener\">NPR<\/a> \u2014 Media report summarizing the Cochrane review and expert commentary (journalism)<\/li>\n<li><a href=\"https:\/\/www.cochrane.org\" target=\"_blank\" rel=\"noopener\">Cochrane Collaboration<\/a> \u2014 Independent review organization; source of the systematic review methodology and pooled trial evidence (research organization)<\/li>\n<\/ul>\n<\/article>\n","protected":false},"excerpt":{"rendered":"<p>Lead: A new Cochrane review published on Jan. 12, 2026, finds that structured physical activity can relieve depressive symptoms as effectively as pharmacological or psychological treatments in many cases. Researchers analyzed 73 randomized controlled trials involving roughly 5,000 people with depression, including participants who were also taking antidepressants. The evidence shows that even light-to-moderate activity &#8230; <a title=\"Exercise is as effective as medication in treating depression, study finds\" class=\"read-more\" href=\"https:\/\/readtrends.com\/en\/exercise-equal-medication-depression\/\" aria-label=\"Read more about Exercise is as effective as medication in treating depression, study finds\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":14191,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_title":"Exercise as effective as medication for depression \u2014 Insight News","rank_math_description":"A Cochrane review of 73 randomized trials (~5,000 people) finds light-to-moderate exercise can reduce depressive symptoms comparable to medication or therapy. Learn practical implications and gaps.","rank_math_focus_keyword":"exercise, depression, Cochrane review, BDNF, antidepressants","footnotes":""},"categories":[2],"tags":[],"class_list":["post-14196","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-top-stories"],"_links":{"self":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/posts\/14196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/comments?post=14196"}],"version-history":[{"count":0,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/posts\/14196\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/media\/14191"}],"wp:attachment":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/media?parent=14196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/categories?post=14196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/tags?post=14196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}